Previous Article | Next Article ![]()
Journal of Clinical Microbiology, May 1998, p. 1209-1213, Vol. 36, No. 5
Victorian Infectious Diseases Reference
Laboratory,
Received 13 October 1997/Returned for modification 19 December
1997/Accepted 6 February 1998
We describe three cases of Anaerobiospirillum
succiniciproducens bacteremia from Australia. We believe one of
these cases represents the first report of A. succiniciproducens bacteremia in a human immunodeficiency virus
(HIV)-infected individual. The other two patients had an underlying
disorder (one patient had bleeding esophageal varices complicating
alcohol liver disease and one patient had non-Hodgkin's lymphoma). A
motile, gram-negative, spiral anaerobe was isolated by culturing blood
from all patients. Electron microscopy showed a curved bacterium with
bipolar tufts of flagella resembling Anaerobiospirillum
spp. Sequencing of the 16S rRNA genes of the isolates revealed no close
relatives (organisms likely to be in the same genus) in the sequence
databases, nor were any sequence data available for A. succiniciproducens. This report presents for the first time the
16S rRNA gene sequence of the type strain of A. succiniciproducens, strain ATCC 29305. Two of the three clinical
isolates have sequences identical to that of the type strain, while the
sequence of the other strain differs from that of the type strain at 4 nucleotides.
Anaerobiospirillum spp.
consist of a group of spiral, motile, gram-negative, anaerobic rods
that have been isolated from the feces of mammals including cats, dogs,
and humans (2, 10). Anaerobiospirillum
succiniciproducens has been implicated as a rare cause of
diarrheal illness and bacteremia in humans (7, 10, 11, 14, 19-22,
25). Previous reports have shown that the infection is usually
associated with or originates from the gastrointestinal tract (10,
15).
In this report, we describe three cases of A. succiniciproducens bacteremia, including the first report of
A. succiniciproducens infection in a human immunodeficiency
virus (HIV)-infected individual. In addition, a search of the sequence
databases did not reveal the 16S rRNA gene sequence of A. succiniciproducens. We sequenced the 16S rRNA genes of the type
strain, strain ATCC 29305, and the three Australian clinical isolates
and present the phenotypic and genotypic characteristics of these three
isolates.
Patient 1.
A 53-year-old man with known alcoholic liver
disease presented with epigastric pain, hematemesis, and melena.
Examination revealed hypotension, hepatomegaly, and peripheral signs of
chronic liver disease. On admission, full blood examination, serum urea levels, and electrolyte levels were normal. He was transfused with 3 units of packed erythrocytes. Esophagogastroscopy revealed bleeding
esophageal varices which were treated by injection sclerotherapy. On
the following day he became febrile (temperature, 38.2°C). There were
no associated symptoms; in particular, there was no diarrhea. Blood was
taken for culture. He received no antibiotics, subsequently became
afebrile, and was discharged 2 days later.
Patient 2.
A 48-year-old homosexual man with advanced AIDS (20 CD4 cells/mm3) was known to have been HIV antibody positive
since 1989. Previous AIDS-defining illnesses included a low-grade
B-cell gastric non-Hodgkin's lymphoma successfully treated with
combination cytotoxic chemotherapy in 1992 and, in 1994, cytomegalovirus retinitis treated with induction and ongoing
maintenance ganciclovir. In February 1996, a biopsy of an axillary
lymph node revealed a T-cell non-Hodgkin's lymphoma. Bone marrow
involvement was demonstrated, and he received a course of oral
etoposide and prednisolone. In August 1996, endoscopy revealed multiple
gastric ulcers that on biopsy demonstrated lymphomatous infiltration,
and a further course of oral chemotherapy was commenced. Two weeks
after chemotherapy he was admitted with lethargy, weight loss, leg
weakness, and urinary frequency related to HIV myelopathy. After 4 days
in hospital he developed high swinging fevers (up to 38.7°C), a
productive cough, and diarrhea. Full blood examination revealed a
hemoglobin concentration of 89 g/liter, a leukocyte count of 2.99 × 109/liter, and a platelet count of 160 × 109/liter. On the blood film, the neutrophils showed a left
shift, toxic granulations, vacuolation, and Dohle bodies. Serum
electrolyte levels and liver function test results were normal. Chest X
rays revealed bilateral lower-zone interstitial changes. Blood was collected for culture. Cultures of cerebrospinal fluid, sputum, and
urine were negative. Cultures of blood for mycobacteria were negative.
Fecal specimens were not collected. Intravenous treatment with
ticarcillin-clavulanate at a dosage of 3.1 g every 6 h was commenced empirically; however, the patient continued to deteriorate and died 7 days later. A request for a postmortem examination was
declined.
Patient 3.
A 57-year-old man with a 3-year history of
non-Hodgkin's lymphoma presented 12 days postchemotherapy complaining
of a 3-day history of fever and night sweats, a 2-week history of
malaise, and a long-standing history of a nonproductive cough. One year prior to admission he had had a splenectomy and had been receiving penicillin prophylaxis. On examination he was found to be febrile (temperature, 38°C), but he had no localizing signs. An
echocardiogram was performed because of aortic stenosis, but no
abnormalities were detected. Three sets of blood cultures were
prepared. Full blood examination revealed a raised leukocyte count with
a predominant lymphocytosis with circulating lymphoma cells and a
marked neutropenia attributed to recent chemotherapy. The patient was
empirically treated intravenously with ticarcillin-clavulanate and
gentamicin for 4 days and then orally with ciprofloxacin for 3 days,
with rapid resolution of his symptoms.
Organism isolation and phenotypic characterization.
The
BACTEC Blood Culture System was used for patients 1 and 3. The blood of
patient 1 was inoculated into a set of BACTEC bottles (6D and 7D
bottles; Johnston Laboratories Inc., Cockeysville, Md.), and BACTEC
Fluorescent Aerobic and Anaerobic Resin bottles were used to culture
the blood of patient 3. The blood of patient 2 was inoculated into one
BacT/Alert aerobic FAN bottle and one BacT/Alert anaerobic bottle
(Organon Teknika Corporation, Durham, N.C.). The contents of the
bottles were subcultured onto 6% horse blood agar, and the plates were
incubated at 37°C for 2 days under anaerobic conditions.
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Three Cases of Anaerobiospirillum
succiniciproducens Bacteremia Confirmed by 16S rRNA Gene
Sequencing
![]()
ABSTRACT
Top
Abstract
Introduction
Case Report
Materials & Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Case Report
Materials & Methods
Results
Discussion
References
![]()
CASE REPORTS
Top
Abstract
Introduction
Case Report
Materials & Methods
Results
Discussion
References
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Case Report
Materials & Methods
Results
Discussion
References
Antibiotic susceptibility testing. The isolates were tested for their susceptibilities to ampicillin-clavulanate, chloramphenicol, ciprofloxacin, clindamycin, imipenem, metronidazole, penicillin, and ticarcillin-clavulanate by the Epsilometer test (Etest; AB Biodisc, Solna, Sweden) according to the manufacturer's recommended guidelines (1). The medium used was brucella agar plus 5% defibrinated sheep blood and 1 mg of vitamin K1 per liter (final concentration). A suspension of organism with a turbidity equivalent to that of a no. 1 McFarland standard was used, and the MICs were read after 48 h of incubation under anaerobic conditions. One of the recommended quality control organisms, Bacteroides fragilis ATCC 25285, was also tested (16).
DNA extraction and purification, PCR, and 16S rRNA gene sequencing. Whole-cell chromosomal DNA was extracted and purified from plate-grown bacteria by the cetyltrimethylammonium bromide method as described previously (24).
The 16S rRNA gene sequence was determined by a previously published procedure (23). Briefly, the entire 16S rRNA genes of the test strains and the type strain ATCC 29305 were amplified by PCR with consensus terminal primers (primers 27F and 1525R). Full-length products of approximately 1.5 kb of double-stranded DNA were purified and sequenced directly with terminal and internal primers specific for 16S rRNA genes (8). Sequencing was performed in an automated DNA sequencer (model 373A DNA sequencer; Applied Biosystems Inc., Foster City, Calif.) by a dye-labelled dideoxy termination method (Taq Dye-Deoxy Terminator Cycle Sequencing Kit; Applied Biosystems Inc.).rRNA sequence alignment and phylogenic tree construction. The complete 16S rRNA gene sequence was compared with other known rRNA gene sequences in the GenBank database and the Ribosome Database Project (RDP) database (University of Illinois, Urbana). The complete 16S rRNA gene sequence was aligned by using the aligned database of the small-subunit rRNA sequences in the RDP database (9). Positions with gaps or uncertain bases were removed, and phylogenetic trees were constructed with the PHYLIP package (3) and the maximum-likelihood program fDNAml (18) implemented by the Australian National Genomic Information Service.
Nucleotide sequence accession number. The sequence of the type strain of A. succiniciproducens, strain ATCC 29305, has been lodged with the GenBank database, and the accession no. is U96412.
| |
RESULTS |
|---|
|
|
|---|
The isolate from patient 1 was recovered from the BACTEC 7D anaerobic bottle after 5 days of incubation. The strain from patient 2 was isolated from the BacT/Alert anaerobic bottle (Organon Teknika) after 4 days of incubation. The strain from patient 3 was recovered from a BACTEC Fluorescent Anaerobic Resin bottle after 2 days of incubation. Positive signals were noted for all three blood culture systems. Gram-negative spiral organisms were seen on Gram smears prepared with samples from the anaerobic blood culture bottles for all patients. Under anaerobic conditions, growth was detected after 48 h of incubation at 37°C but not at 25 or 42°C. No growth occurred under aerobic or microaerobic conditions.
After 48 h the colonies on blood agar were 0.5 to 1 mm in diameter, translucent, and nonhemolytic, with some colonies showing feathery swarming growth. Phase-contrast microscopy revealed spiral-shaped organisms exhibiting a corkscrew-like motility but without the typical rapid darting motility of Campylobacter spp. Gram-stained smears revealed gram-negative spiral cells 0.6 to 0.8 m wide and 4.0 to 8.0 m long (Fig. 1). Upon repeated subculture, there was an increased amount of straight rod-shaped organisms. An electron micrograph revealed a curved bacterium with bipolar tufts of flagella. Staining of the flagella performed with a colony from a plate after 2 days of growth also showed spiral bacteria with polar multitrichous flagella, some with distinctive bipolar tufts (Fig. 2).
|
|
Biochemical tests performed with these isolates showed that reactions
for catalase, oxidase, indole, and nitrate reduction were all negative.
The API-ZYM strips detected the presence of activity for the enzymes
leucine arylamidase,
-galactosidase,
-glucosidase, and
N-acetyl-
-glucosaminidase for ATCC 29305 and the
three clinical isolates. The positive tests with the Rapid ANA II
system were for
o-nitrophenyl-
-D-galactopyranoside
(
-galactosidase),
-glucosidase, glycine aminopeptidase,
arginine aminopeptidase, and serine aminopeptidase for all four
isolates. A profile or microcode of 030441 was obtained.
Gas-liquid chromatography revealed that acetic acid is the major volatile fatty acid that was produced and that succinic acid is the major nonvolatile acid produced from glucose cooked-meat medium.
Table 1 presents the MICs for the clinical isolates and the type strain of A. succiniciproducens, strain ATCC 29305, obtained by the Etest. All isolates were resistant to clindamycin but sensitive to chloramphenicol, imipenem, amoxicillin-clavulanate, and ticarcillin-clavulanate. The isolates from patients 1 and 3 were resistant to metronidazole. The isolate from patient 1 was resistant to penicillin. Although there are no documented breakpoints for ciprofloxacin for anaerobic organisms, for all three isolates MICs were in the susceptible range for aerobic bacteria (17).
|
The complete 16S rRNA gene sequences of the three clinical isolates and type strain ATCC 29305 were determined and compared with all known 16S rRNA sequences found in the sequence databases (RPD and GenBank). The sequences of the isolates from patients 1 and 3 were identical to that of type strain ATCC 29305 across the entire lengths of the 16S rRNA genes, but the sequence of the isolate from patient 2 differed at 4 bases (T instead of C at position 188, A replacing C at position 190, T replacing C at position 597, and A replacing T at position 792). The sequence of type strain ATCC 29035 was found to be most similar to that of the species Ruminobacter amylophilus, with 88.3% sequence similarity. Phylogenetic trees were inferred by a previously described method (23), and a representative example is presented in Fig. 3. Maximum-likelihood (fDNAml), distance matrix, and parsimony (PAUP) methods all gave very similar branching orders. Bootstrap analyses strongly supported the branching of A. succiniciproducens within the gamma subdivision of the proteobacteria, with R. amylophilus being the closest relative.
|
| |
DISCUSSION |
|---|
|
|
|---|
A. succiniciproducens was first isolated in 1976 by
Davis et al. (2) from the throats and cecal contents of
beagle dogs. Recently, another member, Anaerobiospirillum
thomasii (12), was proposed to include a previously
described group of Anaerobiospirillum-like organisms
isolated from feces of mammals. To our knowledge,
Anaerobiospirillum-like organisms or A. thomasii
has not been reported to be associated with bacteremia in humans.
A. succiniciproducens and A. thomasii can be
differentiated by biochemical tests with carbohydrate fermentations and
by the enzyme profiles obtained with API-ZYM strips, notably, the
absence of
-galactosidase and
-glucosidase activities
(12).
A. succiniciproducens is a rare cause of human infection. In a review of infections involving uncommonly encountered motile anaerobic gram-negative bacilli at the Veterans Administration (now the U.S. Department of Veterans Affairs) Wadsworth Medical Center from 1973 to 1985, an Anaerobiospirillum sp. was not isolated (5). A study conducted by the Centers for Disease Control and Prevention (CDC), Atlanta, Ga., reviewed 22 patients (including 4 patients who had been described previously) with A. succiniciproducens bacteremia whose isolates were submitted from 1975 to 1986. While most cases of A. succiniciproducens bacteremia described in the literature occurred in the United States (15, 20, 21), more recent reports from Hong Kong (19), South Africa (14), New Zealand (4), and now Australia suggest that this organism is more prevalent than was previously thought and may occur across wider geographical regions. Better methods of detection by blood culture with automated systems such as the BACTEC Blood Culture System and the BacT/Alert Blood Culture System in laboratories and the increased awareness of the importance of this organism as a cause of human disease may have been factors contributing to the increase in the rate of isolation and detection of this unusual organism.
Previous reports (7, 10, 11, 14, 19-22, 25) have indicated that Anaerobiospirillum spp. are an uncommon cause of gastroenteritis and bacteremia. Most patients with diarrheal disease did not have an underlying disorder, and most patients recovered from the infection (10, 13). In contrast, almost all reported cases of bacteremia (15, 20-22) have been in patients with an underlying illness such as alcoholism, malignancy, diabetes mellitus, and other gastrointestinal disorders. The three patients reported in our study all had underlying disease: one had alcohol-related liver disease complicated by gastrointestinal hemorrhage, one had non-Hodgkin's lymphoma, and the other had advanced AIDS. This suggests that immunosuppressed or immunocompromised hosts may be more susceptible to infection with this organism.
The gastrointestinal tract has been postulated as a likely portal of entry in patients with A. succiniciproducens bacteremia. McNeil et al. (15) reported that 77% of 22 patients with bacteremia had gastrointestinal signs or symptoms, with gastrointestinal bleeding being a feature in 36% of patients, and that on microscopic examination spiral organisms were seen in the feces of some patients. Malnick et al. (10) screened feces for Anaerobiospirillum spp. but failed to detect the organisms in 527 healthy, asymptomatic human subjects but did detect them in 7 of 10 cats and 3 of 10 dogs. This suggests that Anaerobiospirillum spp. are unlikely to be part of the normal gastrointestinal flora of humans. They reported the isolation of A. succiniciproducens or Anaerobiospirillum-like organisms from the feces of 17 humans with diarrhea. Of these 17 patients, detailed information was obtained for only 5 patients, all of whom had pet dogs, which raises the possibility of zoonotic transmission. The source of infection in our three patients was unclear. Gastrointestinal symptoms were absent in our non-HIV-infected individuals, and fecal specimens were not collected from our HIV-infected patient, despite the presence of diarrhea. For our three patients, information was unavailable about contact with domestic animals such as dogs or cats.
Antimicrobial susceptibility testing by various investigators (5, 15) has shown that clinical isolates of A. succiniciproducens are susceptible to carbenicillin, chloramphenicol, and cephalothin and are resistant to vancomycin and nalidixic acid. Susceptibilities to penicillin G, ampicillin, erythromycin, clindamycin, and metronidazole were variable. Although 16 patients in a study by McNeil et al. (15) received antimicrobial treatment, the effect on the outcome of the infection was unclear. For seven of those patients bacteremia was reported to have contributed to their deaths. In the current study, the three isolates were found to be sensitive to chloramphenicol, ciprofloxacin, and imipenem but resistant to clindamycin. Two of the three isolates was also resistant to metronidazole. Because clindamycin and metronidazole are first-line antibiotics for the treatment of infections caused by anaerobic bacteria, susceptibility testing of all isolates is advisable. For all three isolates the MICs to penicillin were increased, and the isolate from patient 1 was found to be resistant to penicillin. Because high levels of penicillin are achievable in blood, infection with isolates for which MICs are of this order may be treatable. Our first patient recovered spontaneously, even though he received no antibiotics. In contrast, the HIV-infected patient died at 7 days, despite intravenous treatment with ticarcillin-clavulanate. The third patient received ticarcillin-clavulanate, gentamicin, and ciprofloxacin, with rapid resolution of symptoms.
Anaerobiospirillum spp. were often erroneously identified as Campylobacter (11, 14, 20, 25) because of similar Gram staining morphologies and corkscrew-like motilities. Demonstration of polar tufts of flagella on a stained smear preparation is crucial in differentiating Anaerobiospirillum from closely related genera. However, not all laboratories have electron microscopy facilities readily available for use for the identification of microbes. In contrast, staining of the flagella by the method described by Kodaka et al. (6) is simple and does not require special equipment. Biochemical tests with commercial kits such as the Rapid ANA II system and Oxoid ANident discs were unhelpful in the identification of this organism because Anaerobiospirillum spp. were not included in the databases provided with those kits. The availability of the 16S rRNA gene sequence will allow more definitive and accurate identification and classification of Anaerobiospirillum isolates.
| |
ACKNOWLEDGMENTS |
|---|
We thank Irene Wilkinson from the Institute of Medical and Veterinary Science of South Australia for performing the gas-liquid chromatography for detection of the volatile and nonvolatile fatty acids of the isolates and Helen Ginis for technical assistance.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Victorian Infectious Disease Reference Laboratory, Western Health Care Network, Old Fairfield Hospital Campus, Yarra Bend Rd., Fairfield, Victoria 3078, Australia. Phone: 61-3-92802523. Fax: 61-3-94816784 or 61-3-92802898. E-mail: weet{at}hna.ffh.vic.gov.au.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | AB Biodisk. 1996. Etest technical guide 1B: susceptibility testing of anaerobes. AB Biodisk, Solna, Sweden. |
| 2. |
Davis, C. P.,
D. Cleven,
J. Brown, and E. Balish.
1976.
Anaerobiospirillum, a new genus of spiral-shaped bacteria.
Int. J. Syst. Bacteriol.
26:498-504 |
| 3. | Felsenstein, J. 1993. PHILIP (phylogeny inference package), version 3.5c. Department of Genetics, University of Washington, Seattle. |
| 4. |
Henry, J.
1989.
Anaerobiospirillum succiniciproducens septicemia "a case of red herrings."
N. Z. J. Med. Lab. Technol.
43:113.
|
| 5. | Johnson, C. C., and S. M. Finegold. 1987. Uncommonly encountered, motile, anaerobic gram-negative bacilli associated with infection. Rev. Infect. Dis. 9:1150-1161[Medline]. |
| 6. |
Kodaka, H.,
A. Y. Armfield,
G. L. Lombard, and V. R. Dowell, Jr.
1982.
Practical procedure for demonstrating bacterial flagella.
J. Clin. Microbiol.
16:948-952 |
| 7. | Lally, R. T., and B. F. Woolfrey. 1988. Anaerobiospirillum succiniciproducens bacteremia. Clin. Microbiol. Newsl. 10:87-88. |
| 8. | Lane, D. J. 1991. 16/23S rRNA sequencing, p. 115-117. In E. Stackenbrandt, and M. Goodfellow (ed.), Nucleic acid techniques in bacterial systematics. John Wiley & Sons, Inc., New York, N.Y. |
| 9. |
Maidak, B. L.,
N. Larsen,
M. J. McCaughey,
R. Overbeek,
G. J. Olsen,
K. Fogel,
J. Blandy, and C. R. Woese.
1994.
The Ribosomal Database Project.
Nucleic Acids Res.
22:3485-3487 |
| 10. |
Malnick, H.,
K. Williams,
J. Phil-Ebosie, and A. S. Levy.
1990.
Description of medium for isolating Anaerobiospirillum spp., a possible cause of zoonotic disease, from diarrheal feces and blood of humans and use of the medium in a survey of human, canine, and feline feces.
J. Clin. Microbiol.
28:1380-1384 |
| 11. |
Malnick, H.,
M. E. M. Thomas,
H. Lotay, and M. Robbins.
1983.
Anaerobiospirillum species isolated from humans with diarrhoea.
J. Clin. Pathol.
36:1097-1101 |
| 12. |
Malnick, H.
1997.
Anaerobiospirillum thomasii sp. nov., an anaerobic spiral bacterium isolated from the feces of cats and dogs and from diarrhoeal feces of human, and emendation of the genus Anaerobiospirillum.
Int. J. Syst. Bacteriol.
47:381-384 |
| 13. | Malnick, H., A. Jones, and J. C. Vickers. 1989. Anaerobiospirillum: cause of a "new" zoonosis. Lancet i:1145-1146. |
| 14. | Marcus, L., E. W. Gove, M. L. Van der Walt, H. J. Koornhof, H. Malnic, and J. G. Kilian. 1996. First reported African case of Anaerobiospirillum succiniciproducens septicemia. Eur. J. Clin. Microbiol. Infect. Dis. 15:741-744[Medline]. |
| 15. | McNeil, M. M., W. J. Martone, and V. R. Dowell, Jr. 1987. Bacteremia with Anaerobiospirillum succiniciproducens. Rev. Infect. Dis. 9:737-742[Medline]. |
| 16. | National Committee for Clinical Laboratory Standards. 1993. Methods for antimicrobial susceptibility testing of anaerobic bacteria: approved standard, 3rd ed. NCCLS document M11-A3. National Committee for Clinical Laboratory Standards, Villanova, Pa. |
| 17. | National Committee for Clinical Laboratory Standards. 1997. Methods for antimicrobial susceptibility test for bacteria that grow aerobically: approved standard, 4th ed. NCCLS document M7-A4. National Committee for Clinical Laboratory Standards, Villanova, Pa. |
| 18. |
Olsen, G. J.,
H. Matsuda,
R. Hagstrom, and R. Overbeek.
1994.
fastDNAml: a tool for construction of phylogenetic trees of DNA sequence using maximum likelihood.
Comput. Appl. Biosci.
10:41-48 |
| 19. | Papasian, C. J., P. J. Kragel, S. Enna-Kifer, R. Kemmis, and K. Webb. 1995. Anaerobiospirillum succiniciproducens sepsis. Clin. Microbiol. Newsl. 17:14-15. |
| 20. | Park, C. H., D. L. Hixon, J. F. Endlich, P. O'Connell, F. T. Bradd, and P. M. Mount. 1985. Anaerobiospirillum succiniciproducens: two case reports. Am. J. Clin. Pathol. 85:73-76. |
| 21. | Rifkin, G. D., and J. E. Opdyke. 1981. Anaerobiospirillum succiniciproducens septicemia. J. Clin. Microbiol. 13:81-83. |
| 22. | Shlaes, D. M., M. J. Dul, and P. I. Lerner. 1982. Anaerobiospirillum bacteremia. Ann. Intern. Med. 97:63-65. |
| 23. | Tee, W., M. L. Dyall-Smith, W. Woods, and D. Eisen. 1996. Probably new species of Desulfovibrio isolated from a pyogenic liver abscess. J. Clin. Microbiol. 34:1760-1764[Abstract]. |
| 24. | Wilson, K. 1990. Preparation of genomic DNA from bacteria. Curr. Protocols Mol. Biol. 1(Suppl. 21):4.1-4.5. |
| 25. | Yuen, K. Y., W. H. Yung, and W. H. Seto. 1989. A case report of Anaerobiospirillum causing septicemia. J. Infect. Dis. 159:153[Medline]. |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»